VAERS Reports 007U20A

VAERS 1286131

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 007U20A

kritisch

Staat: VA
Alter: 79,0
Geschlecht: F
Eingang: 04.05.2021
Impfdatum: 26.01.2021
Beginn: 29.01.2021
Tage bis Beginn: 3,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Anticoagulant therapy Deep vein thrombosis Pulmonary embolism

Symptomtext

Pt has DVT/PE 3 days post vaccination. Pt is being treated with Eliquis.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pulmonary embolism
Hospital-Tage: -
Labordaten: Pt was evaluated in ER/Hospital
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1059661

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 007U20A

mild

Staat: MN
Alter: 69,0
Geschlecht: F
Eingang: 27.02.2021
Impfdatum: 17.02.2021
Beginn: 24.02.2021
Tage bis Beginn: 7,0
Dosis: 1
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Injection site induration Injection site pain Injection site rash Injection site warmth Pallor Rash pruritic Sensitive skin

Symptomtext

One week after I received the 1st dose of the Moderna CoVid-19 vaccine, I developed a bright pink, hard, raised area of very itchy rash at the site of the injection. It was about 2"x3" in size, was very warm and painful to the touch. The size increased over the next couple of days to about 3" in diameter but decreased in symptoms (less pain, less itch, less hard, less raised and less warm). I still have the sensitive area today (Saturday, Feb 27, 12:33 pm) but it has continued to decrease in symptoms. The affected area is still about 3" in diameter but has faded in color (now pale pink).

Weitere VAERSDATA-Felder

Praegender Schweregrund: Injection site induration
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: none
Vorgeschichte: none
Andere Medikamente: none
Allergien: Sulfa, Gadavist
Vorherige Impfungen: -